Scientists have developed a new way of identifying which individuals with clonal haematopoiesis are at increased risk for blood cancer.
Dr Lachelle Weeks of the Dana-Farber Cancer Institute, Massachusetts, USA, and colleagues reported they have di...
1 year ago
A novel treatment for relapsed multiple myeloma is showing good results in an international clinical trial, researchers have reported.
The experimental drug, talquetamab, is a bi-specific antibody therapy which redirects the immune system’s T cell...
1 year ago
